Interestingly, PAK4KO also stimulated the intra-tumoral CD103+CD8+ T-cells, a type of active cytotoxic T-cell that is positively correlated with better prognosis of pancreatic cancer patients [52]. This evidence concerns the gene CD8A and familial pancreatic carcinoma.